Recent Quotes (30 days)

You have no recent quotes
chg | %

RepliCel Life Sciences Inc  

(Public, CNSX:RP)   Watch this stock  
Find more results for RP
Real-time:   12:49PM EST
CNSX real-time data - Disclaimer
Currency in CAD
Range     -
52 week 0.00 - 0.55
Open     -
Vol. 0.00
Mkt cap     -
P/E     -
Div/yield     -
EPS 0.00
Shares     -
Beta     -
Inst. own     -
Apr 29, 2015
Q4 2014 RepliCel Life Sciences Inc Earnings Release
Mar 24, 2015
RepliCel Life Sciences Inc at Biotechnology Industry Organization (BIO) Asia International Conference

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -198.26% -247.92%
Return on average equity -226.16% -316.89%
Employees 4 -
CDP Score - -


401 Georgia St W Suite 2020
+1-604-2488730 (Phone)
+1-604-2488690 (Fax)

Website links


RepliCel Life Sciences Inc. (RepliCel), formerly Newcastle Resources Ltd. is a Canada-based company, engaged in the business of developing and patenting hair follicle cell replication technology. The Company’s cellular replication and implantation technology is designed to rejuvenate damaged, miniaturized hair follicles in balding scalp skin. The Company is developing an autologous cell-based procedure for the treatment of androgenetic alopecia (pattern baldness) and general hair loss in men and women. It is focused on ensuring the safety and demonstrating the efficacy of RepliCel’s cell-based hair regeneration procedure in humans. As of September 30, 2012, the Company‘s subsidiary included TrichoScience Innovations Inc. (TrichoScience).

Officers and directors

Peter K. Jensen Chairman of the Board
Age: 62
David M. Hall President, Chief Executive Officer, Director
Age: 59
Thomas A. Kordyback C.A. Chief Financial Officer
Age: 61
Brooke Hurford Director - Finance, Corporate Secretary
Kevin McElwee Ph.D. Chief Scientific Officer
Age: 43
Gemma Fetterley Vice President - Finance, Treasurer
Age: 34
Darrell Panich Vice President - Clinical Affairs
Age: 41
R. Lee Buckler Vice President, Vice President - Business and Corporate Development
Rolf Hoffmann M.D. Chief Medical Officer, Director
Age: 51
John Challis Director
Age: 66